NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals P Duewell, H Kono, KJ Rayner, CM Sirois, G Vladimer, FG Bauernfeind, ... Nature 464 (7293), 1357-1361, 2010 | 3978 | 2010 |
Macrophages in the pathogenesis of atherosclerosis KJ Moore, I Tabas Cell 145 (3), 341-355, 2011 | 2917 | 2011 |
The NALP3 inflammasome is involved in the innate immune response to amyloid-β A Halle, V Hornung, GC Petzold, CR Stewart, BG Monks, T Reinheckel, ... Nature immunology 9 (8), 857-865, 2008 | 2693 | 2008 |
PPARγ is required for the differentiation of adipose tissue in vivo and in vitro ED Rosen, P Sarraf, AE Troy, G Bradwin, K Moore, DS Milstone, ... Molecular cell 4 (4), 611-617, 1999 | 2607 | 1999 |
Macrophages in atherosclerosis: a dynamic balance KJ Moore, FJ Sheedy, EA Fisher Nature Reviews Immunology 13 (10), 709-721, 2013 | 2581 | 2013 |
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer CR Stewart, LM Stuart, K Wilkinson, JM Van Gils, J Deng, A Halle, ... Nature immunology 11 (2), 155-161, 2010 | 1694 | 2010 |
MiR-33 contributes to the regulation of cholesterol homeostasis KJ Rayner, Y Suárez, A Dávalos, S Parathath, ML Fitzgerald, N Tamehiro, ... science 328 (5985), 1570-1573, 2010 | 1445 | 2010 |
Scavenger receptors class AI/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages VV Kunjathoor, M Febbraio, EA Podrez, KJ Moore, L Andersson, S Koehn, ... Journal of Biological Chemistry 277 (51), 49982-49988, 2002 | 1246 | 2002 |
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation FJ Sheedy, A Grebe, KJ Rayner, P Kalantari, B Ramkhelawon, ... Nature immunology 14 (8), 812-820, 2013 | 929 | 2013 |
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides KJ Rayner, CC Esau, FN Hussain, AL McDaniel, SM Marshall, ... Nature 478 (7369), 404-407, 2011 | 825 | 2011 |
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways H Björkbacka, VV Kunjathoor, KJ Moore, S Koehn, CM Ordija, MA Lee, ... Nature medicine 10 (4), 416-421, 2004 | 817 | 2004 |
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis KJ Rayner, FJ Sheedy, CC Esau, FN Hussain, RE Temel, S Parathath, ... The Journal of clinical investigation 121 (7), 2921-2931, 2011 | 810 | 2011 |
Scavenger receptors in atherosclerosis: beyond lipid uptake KJ Moore, MW Freeman Arteriosclerosis, thrombosis, and vascular biology 26 (8), 1702-1711, 2006 | 740 | 2006 |
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling A Dávalos, L Goedeke, P Smibert, CM Ramírez, NP Warrier, U Andreo, ... Proceedings of the National Academy of Sciences 108 (22), 9232-9237, 2011 | 736 | 2011 |
The role of PPAR-γ in macrophage differentiation and cholesterol uptake KJ Moore, ED Rosen, ML Fitzgerald, F Randow, LP Andersson, ... Nature medicine 7 (1), 41-47, 2001 | 664 | 2001 |
MicroRNA regulation of atherosclerosis MW Feinberg, KJ Moore Circulation research 118 (4), 703-720, 2016 | 633 | 2016 |
CD36 mediates the innate host response to β-amyloid JB El Khoury, KJ Moore, TK Means, J Leung, K Terada, M Toft, ... The Journal of experimental medicine 197 (12), 1657-1666, 2003 | 582 | 2003 |
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress TA Seimon, MJ Nadolski, X Liao, J Magallon, M Nguyen, NT Feric, ... Cell metabolism 12 (5), 467-482, 2010 | 542 | 2010 |
Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain LM Stuart, J Deng, JM Silver, K Takahashi, AA Tseng, EJ Hennessy, ... The Journal of cell biology 170 (3), 477-485, 2005 | 508 | 2005 |
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice KJ Moore, VV Kunjathoor, SL Koehn, JJ Manning, AA Tseng, JM Silver, ... The Journal of clinical investigation 115 (8), 2192-2201, 2005 | 471 | 2005 |